USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland and Labrador; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon
Israel
International country outside of the USA, Israel and Canada.
Grants to USA, Canada, and International researchers for projects related to epilepsy prevention, therapy, and treatments. Applicants must submit a letter of intent prior to applying. The goal of the program is to encourage young researchers to develop independent studies that are distinct from that of their mentors.
Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicants will be required to discuss how this avenue of research is independent of their mentor’s research and will lead them to a path of independent epilepsy research. Studies that will provide new directions for epilepsy therapy, prevention, and, ultimately, a cure and that will allow applicants to collect the data necessary to support a grant application to the National Institutes of Health or a similar granting agency are encouraged.
CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender-diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.
Priority Areas
CURE Epilepsy’s priority research areas focus on those that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with CURE Epilepsy's mission.
Funding requests may include salary support for the Principal Investigator (PI), technical staff, supplies necessary to perform the work, animal costs, publication fees, and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research.
For additional information on eligible costs, see: https://www.cureepilepsy.org/wp-content/uploads/2022/10/2023-Taking-Flight-Award-LOI-Full-Propsal-Guidelines.pdf#page=11
Estimated Size of Grant:
- One year
- Anticipated Project Start Date: September 2023
- CURE Epilepsy does not provide deadline extensions.
Apply online: https://proposalcentral.com/
Questions regarding these guidelines are welcome and should be directed to the Research Team at Research@CUREepilepsy.org or 312-255-1801.
CURE
420 N. Wabash Avenue, Suite 650
Chicago, IL 60611
Mailing address:
PO Box 10572
Chicago, IL 60610